Special vascular risk with Canagliflozin

The peer review history for this article is available at https://www.webofscience.com/api/gateway/wos/peer-review/10.1111/dom.70292. The data that support the findings of this study are openly available in Diabetes Obes Metabolism at http://doi:10.1111/dom.15901, and in the NEJM at http://doi:10.1056/NEJMoa1811744.

Authors

Institutions

Publication Details

Journal
Diabetes Obesity and Metabolism
Published
2025-11-20
DOI
https://doi.org/10.1111/dom.70292
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Special vascular risk with Canagliflozin

L Caspary
Diabetes Obesity and Metabolism
Diabetes Treatment and Management
article

Special vascular risk with Canagliflozin

L Caspary
article en

Abstract

The peer review history for this article is available at https://www.webofscience.com/api/gateway/wos/peer-review/10.1111/dom.70292. The data that support the findings of this study are openly available in Diabetes Obes Metabolism at http://doi:10.1111/dom.15901, and in the NEJM at http://doi:10.1056/NEJMoa1811744.

Diabetes Obesity and MetabolismVol. 28(2)
Hannover Re (Germany) (DE)
Openalex Percentile: Top 52%
Diabetes Treatment and Management
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Special vascular risk with Canagliflozin — L Caspary · Diabetes Obesity and Metabolism (2025) | TGRS Research Map | TGRS